Viiv Healthcare:在没有上诉的情况下,英国国家医疗服务体系应在威尔士两个月内、英格兰三个月内提供长期效应的Cabotegravir用于预防
Viiv Healthcare:在没有上诉的情况下,英国国家医疗服务体系应在威尔士两个月内、英格兰三个月内提供长期效应的Cabotegravir用于预防
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.